Considerations for management of patients with diabetic macular edema: optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration
Diabetes is one of the leading causes of premature blindness in the world [1 –3]. A key contributing factor to this is inadequate glycemic control [4,5]; despite the advent of multiple new agents to treat hyperglycemia, with lower risk of weight gain and hypoglycemia than previous treatments, many people with diabetes are not meeting their glycemic targets [6,7]. This incr eases the risk of developing serious comorbidities, such as cardiovascular disease, stroke, nephropathy, and neuropathy [2,8,9].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: W David Strain, Xavier Cos, Christian Pr ünte Tags: Review Source Type: research
More News: Blindness | Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Neurology | Opthalmology | Stroke